Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Quarterly results
Director comp.
Director departure
Appointed director
CC transcript
CIGNA CORP (CI) Create: Alert

All | News | Filings
Date FiledTypeDescription
12/20/2018 8-K Completion of Acquisition or Disposition of Assets, Creation of a Direct Financial Obligation or an Obligation under an Off-B...
Docs: "Amended and Restated Certificate of Incorporation of Cigna Holding Company (formerly known as Cigna Corporation)",
"Amended and Restated By-Laws of Cigna Holding Company (formerly known as Cigna Corporation)",
"Second Supplemental Indenture, by and among Express Scripts Holding Company, Cigna Holding Company (formerly known as Cigna Corporation) and U.S. Bank National Association, as Trustee, to that certain base indenture, by and among Halfmoon Parent, Inc. (now known as Cigna Corporation) and U.S. Bank National Association (as supplemented by that certain first supplemental indenture thereto dated as of September 17, 2018)",
"Additional Guarantor Supplement, by Express Scripts Holding Company and Cigna Holding Company (formerly known as Cigna Corporation) to that certain Revolving Credit and Letter of Credit Agreement, by and among Cigna Corporation (now known as Cigna Holding Company), Halfmoon Parent, Inc. (now known as Cigna Corporation), JPMorgan Chase Bank, N.A., as administrative agent, and the other parties thereto",
"Additional Guarantor Supplement, by Express Scripts Holding Company and Cigna Holding Company (formerly known as Cigna Corporation) to that certain Term Loan Credit Agreement, by and among Cigna Corporation (now known as Cigna Holding Company), Halfmoon Parent, Inc. (now known as Cigna Corporation), Morgan Stanley Senior Funding, Inc., as administrative agent, and the other parties thereto",
"Supplemental Indenture No. 11, by and among Cigna Corporation (formerly known as Halfmoon Parent, Inc.), Cigna Holding Company (formerly known as Cigna Corporation) and U.S. Bank National Association, as Trustee, to that certain base indenture, by and among Cigna Corporation (now known as Cigna Holding Company) and U.S. Bank National Association, as Trustee",
"Supplemental Indenture No. 1, by and among Cigna Corporation (formerly known as Halfmoon Parent, Inc.), Cigna Holding Company (formerly known as Cigna Corporation) and HSBC Bank USA, National Association (as successor to Marine Midland Bank, N.A.), as Trustee, to that certain base indenture, by and among Cigna Corporation (now known as Cigna Holding Company) and HSBC",
"Supplemental Indenture No. 1, by and among Cigna Corporation (formerly known as Halfmoon Parent, Inc.), Cigna Holding Company (formerly known as Cigna Corporation) and Deutsche Bank Trust Company Americas, a New York banking corporation (as successor to Bankers Trust Company), as Trustee, to that certain base indenture, by and among Cigna Corporation (now known as Cigna Holding Company) and Deutsche Bank",
"Cigna Completes Combination with Express Scripts, Establishing a Blueprint to Transform the Health Care System"
12/19/2018 8-K Regulation FD Disclosure
12/13/2018 8-K Regulation FD Disclosure
11/21/2018 8-K Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Letter Agreement, by and among Cigna Corporation, Express Scripts Holding Company, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc"
11/21/2018 8-K Regulation FD Disclosure
11/01/2018 8-K Quarterly results
Docs: "Total revenues 1 increased 9% to $11.5 billion in the third quarter o Shareholders' net income for the third quarter was $772 million, or $3.14 per share o Adjusted income from operations 2 in the third quarter was $945 million, or $3.84 per share"
09/27/2018 8-K Quarterly results
09/21/2018 8-K Acquisition/merger/asset purchase announced
Docs: "Indenture, between Halfmoon Parent, Inc. and U.S. Bank National Association, as trustee",
"Supplemental Indenture, between Halfmoon Parent, Inc. and U.S. Bank National Association, as trustee",
"Registration Rights Agreement, by and among Halfmoon Parent, Inc. and Morgan Stanley & Co. LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, J.P. Morgan Securities LLC and Wells Fargo Securities, LLC, as representatives of the Initial Purchasers named in Schedule I to the Purchase Agreement"
09/17/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "U.S. DEPARTMENT OF JUSTICE GRANTS CLEARANCE TO CIGNA’S ACQUISITION OF EXPRESS SCRIPTS"
09/11/2018 8-K Regulation FD Disclosure
09/04/2018 8-K Regulation FD Disclosure, Financial Statements and Exhibits
Docs: "Unaudited Pro Forma Financial Information"
08/29/2018 8-K Regulation FD Disclosure
08/24/2018 8-K Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits
Docs: "BLOOMFIELD, Conn. – August 24, 2018 –"
08/21/2018 8-K Regulation FD Disclosure
08/13/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "A SECOND LEADING INDEPENDENT PROXY ADVISORY FIRM GLASS LEWIS RECOMMENDS CIGNA SHAREHOLDERS VOTE "FOR" ACQUISITION OF EXPRESS SCRIPTS"
08/10/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "Leading Independent Proxy Advisory Firm ISS Recommends Cigna Shareholders Vote "For" Acquisition of Express Scripts Cigna Reminds Shareholders to Vote "FOR" the Transformative Combination Today"
08/09/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "The elimination of rebates does not pose a material threat to the value of our combination with Express Scripts"
08/08/2018 8-K Investor presentation
Docs: "Cigna Corporation presentation titled "Cigna Reiterates Support for Proposed Merger with Express Scripts""
08/07/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "Mr. Icahn does not represent the interests of Cigna shareholders"
08/02/2018 8-K Quarterly results
Docs: "Total revenues 1 increased 10% to $11.5 billion in the second quarter o Shareholders’ net income for the second quarter was $806 million, or $3.29 per share o Adjusted income from operations 2 in the second quarter was $955 million, or $3.89 per share"
07/02/2018 8-K Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of...
Docs: "Amendment No. 1, to the Agreement and Plan of Merger, by and among Cigna Corporation, Express Scripts Holding Company, Halfmoon Parent, Inc., Halfmoon I, Inc. and Halfmoon II, Inc",
"BLOOMFIELD, Conn. – July 2, 2018 –"
05/31/2018 8-K Regulation FD Disclosure
05/03/2018 8-K Quarterly results
Docs: "Total revenues 1 increased 9% to $11.4 billion in the first quarter o Shareholders’ net income for the first quarter was $915 million, or $3.72 per share o Adjusted income from operations 2 in the first quarter was $1.0 billion, or $4.11 per share o Global medical customer base 3 is now projected to grow in the range of 400,000 to 500,000 lives in 2018"
04/30/2018 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submission of Matters to a Vote of Security Holders...
Docs: "Restated Certificate of Incorporation of Cigna Corporation, as last amended April 25, 2018",
"By-Laws of Cigna Corporation, as last amended April 25, 2018"
04/25/2018 8-K Quarterly results
04/23/2018 8-K Quarterly results
04/12/2018 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Revolving Credit and Letter of Credit Agreement",
"Term Loan Credit Agreement"
03/15/2018 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
03/13/2018 8-K Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financi...
Docs: "Agreement and Plan of Merger, by and among Cigna Corporation, Express Scripts Holding Company, Halfmoon Parent, Inc., Halfmoon I, Inc., and Halfmoon II, Inc",
"Amendment to By-Laws of Cigna Corporation"
03/08/2018 8-K Other Events, Financial Statements and Exhibits
Docs: "CIGNA TO ACQUIRE EXPRESS SCRIPTS FOR"
02/27/2018 8-K Regulation FD Disclosure
02/01/2018 8-K Quarterly results
Docs: "Adjusted income from operations 1 for 2017 was $2.7 billion, or $10.46 per share o Total revenues are expected to grow 7% to 8% in 2018, with projected growth of 300,000 to 500,000 global medical customers 2 o Adjusted income from operations 1,3 is projected to be in the range of $3.08 billion to $3.20 billion in 2018, or $12.40 to $12.90 per share 4 , which represents per share growth of 19% to 23% over 2017 BLOOMFIELD, CT, February 1, 2018"
01/09/2018 8-K Quarterly results
12/22/2017 8-K Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Financial ...
Docs: "Fifth Amended and Restated Revolving Credit and Letter of Credit Agreement"
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy